Laparoscopic adjustable gastric banding induces prolonged satiety: A randomized blind crossover study

被引:148
作者
Dixon, AFR [1 ]
Dixon, JB [1 ]
O'Brien, PE [1 ]
机构
[1] Monash Univ, Ctr Obes Res & Educ, Alfred Hosp, Melbourne, Vic 3181, Australia
关键词
D O I
10.1210/jc.2004-1546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The sustainability of surgically induced weight loss implies that energy homeostasis is favorably altered. We investigated the hypothesis that laparoscopic adjustable gastric banding (LAGB) induces prolonged satiety and that plasma ghrelin is involved. Seventeen weight-stable subjects who had achieved LAGB-induced weight loss attended blind crossover breakfast tests, one with optimal band restriction and one with reduced restriction. Standardized meals were consumed (0900 h) after 14-h fasting. Satiety visual analog scales were completed hourly (0700-1100 h) before and after feeding. Blood glucose, plasma insulin, ghrelin, and leptin levels were measured. Seventeen body mass index-matched controls were tested. Optimal restriction was associated with significantly greater fasting and postprandial satiety levels than reduced restriction (P < 0.01). Glucose, insulin, ghrelin, and leptin levels did not alter between optimal and reduced restriction. LAGB subjects displayed higher ghrelin (+12%, P = 0.13) and lower glucose (-17%, P = 0.018), insulin (-33%, P = 0.016), and leptin (-32%, P = 0.05) 4-h area under the curve levels than controls. Optimal LAGB restriction increased fasting and postprandial satiety levels. This supports the hypothesis that LAGB provides prolonged satiety, present even during fasting, favorably influencing energy homeostasis. Plasma insulin, leptin, and ghrelin appeared unrelated to the satiety effect and displayed orexigenic compensatory changes. Identifying the mechanisms underlying LAGB-induced satiety may assist the understanding of human energy homeostasis and obesity.
引用
收藏
页码:813 / 819
页数:7
相关论文
共 37 条
  • [1] Anderson JW, 2001, AM J CLIN NUTR, V74, P579
  • [2] MORBID-OBESITY TREATED BY GASTROPLASTY - RADIONUCLIDE GASTRIC-EMPTYING STUDIES
    ARNSTEIN, NB
    SHAPIRO, B
    ECKHAUSER, FE
    DMUCHOWSKI, CF
    KNOL, JA
    STRODEL, WE
    NAKAJO, M
    SWANSON, DP
    [J]. RADIOLOGY, 1985, 156 (02) : 501 - 504
  • [3] Medicinal strategies in the treatment of obesity
    Bray, GA
    Tartaglia, LA
    [J]. NATURE, 2000, 404 (6778) : 672 - 677
  • [4] WEIGHT-LOSS AND DIETARY-INTAKE AFTER VERTICAL BANDED GASTROPLASTY AND ROUX-EN-Y GASTRIC BYPASS
    BROLIN, RE
    ROBERTSON, LB
    KENLER, HA
    CODY, RP
    [J]. ANNALS OF SURGERY, 1994, 220 (06) : 782 - 790
  • [5] Busetto L, 1996, INT J OBESITY, V20, P539
  • [6] CHRISTIAN PE, 1986, J NUCL MED, V27, P1686
  • [7] Colquitt JL, 2009, COCHRANE DATABASE SY, V15, DOI [10.1002/14651858.CD003641.pub3, DOI 10.1002/14651858.CD003641]
  • [8] Roles for ghrelin in the regulation of appetite and body weight
    Cummings, DE
    Shannon, MH
    [J]. ARCHIVES OF SURGERY, 2003, 138 (04) : 389 - 396
  • [9] A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
    Cummings, DE
    Purnell, JQ
    Frayo, RS
    Schmidova, K
    Wisse, BE
    Weigle, DS
    [J]. DIABETES, 2001, 50 (08) : 1714 - 1719
  • [10] Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.
    Cummings, DE
    Weigle, DS
    Frayo, RS
    Breen, PA
    Ma, MK
    Dellinger, EP
    Purnell, JQ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1623 - 1630